SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
--------
SCHEDULE 13G
INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
TRANSCEND THERAPEUTICS, INC.
-----------------------------------------------------------------
(Name of Issuer)
COMMON STOCK
-----------------------------------------------------------------
(Title of Class of Securities)
89353T 10 2
-----------------------------------------------------------------
(CUSIP Number)
--------
<PAGE>
- --------------------------- -------------------------
CUSIP No. 89353T 10 2 13G Page 2 of 5 Pages
- --------------------------- -------------------------
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
Nestle S.A.
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Switzerland
- -------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER 0
SHARES --------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER 789,650
OWNED BY EACH --------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER 0
PERSON WITH --------------------------------------------------
8 SHARED DISPOSITIVE POWER 789,650
- -------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
789,650
- -------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [ ]
- -------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 13.7%
- -------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
CO
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
Page 3 of 5 Pages
Item 1(a). Name of Issuer: TRANSCEND THERAPEUTICS, INC.
Item 1(b). Address of Issuer's Principal Executive Offices:
Item 2(a). Name of Person Filing: Nestle S.A.
Item 2(b). Address of Principal Business Office or, if None, Residence:
Avenue Nestle 55, CH-1800, Vevey, Switzerland
Item 2(c). Citizenship: Switzerland
Item 2(d). Title of Class of Securities: Common Stock
Item 2(e). CUSIP Number: 89353T 10 2
Item 3. If this statement is filed pursuant to Rules 13d-1(b), or
13d-2(b), check whether the person filing is a: Not
applicable, filed pursuant to Rule 13d-1(c)
(a) [ ] Broker or dealer registered under Section 15 of
the Act,
(b) [ ] Bank as defined in Section 3(a)(6) of the Act,
(c) [ ] Insurance Company as defined in Section 3(a)(19) of
the Act,
(d) [ ] Investment Company registered under Section 8
of the Investment Company Act,
(e) [ ] Investment Adviser registered under Section
203 of the Investment Advisers Act of 1940,
(f) [ ] Employee Benefit Plan, Pension Fund which is
subject to the provisions of the Employee
Retirement Income Security Act of 1974 or
Endowment Fund; see 13d-1(b)(1)(ii)(F),
(g) [ ] Parent Holding Company, in accordance with
Rule 13d-1(b)(ii)(G); see Item 7,
(h) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(H).
<PAGE>
Page 4 of 5 Pages
Item 4. Ownership: As of December 31, 1997, Nestle USA, Inc. beneficially
owned an aggregate of 789,650 shares of Common Stock of the Company
which represented approximately 13.7% of the outstanding shares.
Nestle USA, Inc. is an indirect wholly-owned subsidiary of Nestle
S.A. See Exhibit 99.1.
Item 5. Ownership of Five Percent or Less of a Class: Not Applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another Person: Not
Applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on by the Parent Holding Company: Nestle
USA, Inc., CO
Item 8. Identification and Classification of Members of the Group: Not
Applicable.
Item 9. Notice of Dissolution of Group: Not Applicable.
Item 10. Certification: Not Applicable.
<PAGE>
Page 5 of 5 Pages
SIGNATURES
After reasonable inquiry and to the best of our knowledge and
belief, we certify that the information set forth in this statement is
true, complete and correct.
Date: February 2, 1998 NESTLE S.A.
By: /s/ Hans Peter Frick
----------------------
Name:Hans Peter Frick
Title: Senior Vice President
<PAGE>
INDEX TO EXHIBITS
Exhibit No. Exhibit
----------- -------
99.1 Item 4 Information
Exhibit 99.1
Nestle USA, Inc., a Delaware Corporation, is an indirect wholly-owned
subsidiary of Nestle S.A.
